pSivida completes recruitment stage of BrachySil trials

Perth-headquartered bio-nanotech company pSivida Ltd has completed the recruitment stage of the second phase of a clinical study of cancer treatment technology BrachySil in the treatment of inoperable pancreatic cancer.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNIQ sponsored byECU School of Business and Law


6th-Australian Institute of Management WA20,000
7th-Murdoch University16,584
8th-South Regional TAFE10,549
9th-Central Regional TAFE10,000
10th-The University of Notre Dame Australia6,708
48 tertiary education & training providers ranked by total number of students in WA

Number of Employees

BNiQ Disclaimer